Skip to content

Clinical trials

Precursor Cell Lymphoblastic Leukemia-Lymphoma trials in Canada

Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.

Filters: Condition: Precursor Cell Lymphoblastic Leukemia-Lymphoma Country / region: Canada Clear all

168 trials match Source: ClinicalTrials.gov registrations

Trials started per year

By phase, 2000 to 2026.

Trials started per year
CategoryTrials
20003
20013
20027
20033
20045
20057
20067
200710
20086
200910
20105
20116
20125
20138
20146
20158
20162
20179
20182
20197
20205
20213
202211
20234
20242
20254
20262

Status

Trials by registry status. Select a bar to filter.

Trials by status
CategoryTrials
Completed112
Recruiting18
Terminated15
Active, not recruiting12
Unknown status8
Not yet recruiting2
Withdrawn1

Top lead sponsors

A sponsor with a page on Pharma Observatory links to it.

Top lead sponsors
CategoryTrials
Children's Oncology Group40
National Cancer Institute (NCI)15
University of Alberta9
Novartis Pharmaceuticals7
Dana-Farber Cancer Institute6
Kiadis Pharma5
University Health Network, Toronto5
Bristol-Myers Squibb4
The Hospital for Sick Children4
Therapeutic Advances in Childhood Leukemia Consortium4

Top conditions

MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.

Top conditions
CategoryTrials
Precursor Cell Lymphoblastic Leukemia-Lymphoma168
Leukemia49
Leukemia, Myeloid, Acute35
Burkitt Lymphoma33
Recurrence28
Lymphoma, Non-Hodgkin23
Leukemia, Lymphocytic, Chronic, B-Cell21
Lymphoma20
Leukemia, Biphenotypic, Acute18
Lymphoma, Large B-Cell, Diffuse17

Trials

Showing 51 to 75 of 168. Each trial links to its page on Pharma Observatory.

68 more trials match. See them on Pharma Observatory

Recently changed trials

Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.

Go deeper on Pharma Observatory

Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.